Implantable biomaterials having engineered functional surfaces
US-10034967-B2 · Jul 31, 2018 · US
US10314949B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10314949-B2 |
| Application number | US-201816047297-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 27, 2018 |
| Priority date | Sep 26, 2002 |
| Publication date | Jun 11, 2019 |
| Grant date | Jun 11, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Implantable materials having defined patterns of affinity regions for binding endothelial cells and providing for directed endothelial cell migration across the surface of the material. The affinity regions include photochemically altered regions of a material surface and physical members patterned on the material surface that exhibit a greater affinity for endothelial cell binding and migration than the remaining regions of the material surface.
Opening claim text (preview).
What is claimed is: 1. An implantable medical device made from a biocompatible material, the biocompatible material forming at least one surface of the implantable medical device, the at least one surface of the biocompatible material further having a patterned array of functional features on the at least one surface of the biocompatible material, wherein each of functional features has a surface energy higher than a surface energy of a remainder of the at least one surface of the biomaterial, and wherein the patterned array of functional features has a spacing between adjacent functional features configured to promote cell propagation between adjacent functional features and along the at least one surface of the implantable medical device. 2. The implantable medical device of claim 1 , wherein the spacing between adjacent functional features is between about 10 μm to about 75 μm. 3. The implantable medical device according to claim 1 , wherein each of the functional features further comprises photochemically altered regions of the biocompatible material. 4. The implantable medical device according to claim 3 , wherein each of the photochemically altered regions further comprises a titanium oxide. 5. The implantable medical device according to claim 1 , wherein the biocompatible material further comprises a component made from nickel-titanium alloy. 6. The implantable medical device according to claim 1 , wherein each of the functional features is nickel-titanium alloy. 7. The implantable medical device according to claim 1 , wherein each of the functional features comprises a focal adhesion point for affinity binding of endothelial cells. 8. The implantable medical device according to claim 7 , wherein each of the focal adhesion points has a binding affinity for endothelial cells that is greater than a binding affinity of the native implantable biomaterial. 9. An implantable biomaterial having at least one surface thereof that comprises the biomaterial and a defined pattern of a plurality of functional features having a height above the at least one surface greater than 0μ, each of the plurality functional features having a greater endothelial cell binding affinity greater than an endothelial cell binding affinity of the biomaterial, wherein each of the functional features further comprise photochemically altered regions of the biocompatible material. 10. The implantable biomaterial according to claim 9 , wherein the functional features have a height between greater than 0 μ to about 3.0 μ. 11. The implantable biomaterial according to claim 9 , wherein each of the functional features comprises a focal adhesion point for affinity binding of endothelial cells. 12. The implantable biomaterial according to claim 9 , wherein each of the functional features has a width between about 10 μm to about 75 μm. 13. The implantable biomaterial according to claim 9 , further comprising a gap distance between adjacent functional features between about 10 μm to about 75 μm.
Other inorganic materials not covered by A61L31/022 - A61L31/026 · CPC title
for preferentially controlling or promoting the growth of specific types of cells or tissues · CPC title
Prostheses implantable into the body · CPC title
Special surfaces of prostheses, e.g. for improving ingrowth (A61F2/30767 takes precedence) · CPC title
Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (dental prostheses A61C13/00; artificial kidneys A61M1/14; artificial hearts A61M60/00) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.